Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.920
-0.030 (-0.61%)
Apr 24, 2025, 4:00 PM EDT - Market closed
AVTX's stock price has decreased by -62.15% in the past year and price targets may not have had time to catch up.

Avalo Therapeutics Analyst Ratings

Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$34.20
Upside
+595.12%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Jefferies
Jefferies
Strong Buy
Initiates
$23
Strong Buy Initiates $23 +367.48% Mar 25, 2025
Stifel
Stifel
Strong Buy
Initiates
$36
Strong Buy Initiates $36 +631.71% Mar 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 20, 2025
Piper Sandler
Piper Sandler
Buy
Initiates
$48
Buy Initiates $48 +875.61% Feb 28, 2025
BTIG
BTIG
Strong Buy
Initiates
$40
Strong Buy Initiates $40 +713.01% Dec 19, 2024
LUCID CAPITAL MARKETS
LUCID CAPITAL MARKETS
Strong Buy
Initiates
$24
Strong Buy Initiates $24 +387.80% Dec 17, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Initiates
n/a
Hold Initiates n/a n/a Oct 24, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$35
Buy Upgrades $35 +611.38% Apr 16, 2024
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 27, 2023
RBC Capital
RBC Capital
Hold
Downgrades
$2,160$180
Hold Downgrades $2,160$180 +3,558.54% Jun 27, 2023
RBC Capital
RBC Capital
Buy
Maintains
$4,080$2,160
Buy Maintains $4,080$2,160 +43,802.44% May 10, 2023
Jefferies
Jefferies
Sell
Downgrades
$720
Sell Downgrades $720 +14,534.15% Feb 8, 2023
Jefferies
Jefferies
Hold
Downgrades
$14,400$2,160
Hold Downgrades $14,400$2,160 +43,802.44% Mar 3, 2022
RBC Capital
RBC Capital
Buy
Maintains
$14,400$11,520
Buy Maintains $14,400$11,520 +234,046.34% Mar 3, 2022
RBC Capital
RBC Capital
Buy
Initiates
$17,280
Buy Initiates $17,280 +351,119.51% Sep 24, 2021